Breaking News

Beroni Group to Build New R&D Center in China

The new center will help the company develop new drugs and medicines to cater for the vast needs of the Chinese market.

Author Image

By: Charlie Sternberg

Associate Editor

Beroni Group, an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for treatment of global diseases, has signed a contract to build a new Research & Development center in the Zhuhai National High-Tech Industrial Development Zone in China.   The new facility will house preclinical research labs, manufacturing process development labs, and a GMP pilot manufacturing plant.   The new R&amp...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters